How "bubble magic" powers the creation of smaller soft robots
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Dec-2025 01:11 ET (23-Dec-2025 06:11 GMT/UTC)
Prof. Guoying Gu team from Shanghai Jiao Tong University unveiled millimeter-scale soft robots today, solving a minimally invasive surgery hurdle: navigating narrow body orifices. They modified silicone with accelerators/thickeners to fix traditional bubble casting’s interfacial instability, making 1–3mm robots in 30 minutes via mini bubble casting. These robots can retrieve clots and check lungs; next, they’ll add sensors and hydrogel drug coatings for "in-body pharmacies."
Targeting a specialized group of histones is safe and opens new therapeutic opportunities for treating blood cancers. This is the main finding of the latest research by Dr Marcus Buschbeck and Dr René Winkler, researchers at the Josep Carreras Leukaemia Research Institute. Experimental results confirm that the removal of any of the three proteins of the macroH2A family of histones, linked to Acute Myeloid Leukaemia, is well tolerated in mice and has no major effect on their health.
- Science learns from nature's methods
- Potential benefits for future therapies against cancer and Alzheimer's disease
- Joint research by TUM and Helmholtz Munich
In the fight against disease, programmed cell death – also known as apoptosis – is a key protective function of the body. It breaks down cells that are damaged or have undergone dangerous changes. However, cancer cells often manage to override this mechanism. A research team at the Technical University of Munich (TUM) has now succeeded in identifying a new molecular switch in this process and elucidating how it works.